Effects of PRI-2191—A low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat

Armstrong, 1996, The inducible 70,000 molecular/weight heat shock protein is expressed in the degenerating dentate hilus and piriform cortex after systemic administration of kainic acid in the rat, Neuroscience, 74, 685, 10.1016/0306-4522(96)00164-9 Boonstra, 2001, 1 alpha,25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells, J. Immunol., 167, 4974, 10.4049/jimmunol.167.9.4974 Brewer, 2001, Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons, J. Neurosci., 21, 98, 10.1523/JNEUROSCI.21-01-00098.2001 Budziszewska, 2001, Estrone, but not 17 beta-estradiol, attenuates kainate-induced seizures and toxicity in male mice, Exp. Clin. Endocrinol. Diabetes, 109, 168, 10.1055/s-2001-14841 Calabrese, 2002, Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance, J. Neurosci. Res., 68, 65, 10.1002/jnr.10177 Ferrer, 1995, Induction of heat-shock protein-70 messenger RNA and protein following systemic kainite injection in the rat: evidence of protein axonal transport, Neuroscience, 69, 1111, 10.1016/0306-4522(95)00313-8 Frechilla, 2000, Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat stratum, Mol. Brain Res., 76, 306, 10.1016/S0169-328X(00)00012-7 Garcion, 2002, New clues about vitamin D functions in the nervous system, Trends Endocrinol. Metab., 13, 100, 10.1016/S1043-2760(01)00547-1 Gurlek, 2002, Modulation of growth factor/cytokine synthesis and signaling by 1α,25-dihydroxyvitamin D3: Implications in cell growth and differentiation, Endocr. Rev., 23, 763, 10.1210/er.2001-0044 Ibi, 2001, Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture, Neuropharmacology, 40, 761, 10.1016/S0028-3908(01)00009-0 Jaworska-Feil, 1999, Effects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brain, J. Neural Transm., 106, 395, 10.1007/s007020050167 Jaworska-Feil, 2001, Protective effects of TRH and its stable analogue, RGH 2202, on kainate-induced seizures and neurotoxicity in rodents, Epilepsy Res., 43, 67, 10.1016/S0920-1211(00)00178-9 Krueger, 1999, Cell specific expression of Hsp70 in neurons and glia of the rat hippocampus after hyperthermia and kainic acid-induced seizure activity, Brain Res., Mol. Brain Res., 71, 265, 10.1016/S0169-328X(99)00198-9 Kubek, 1993, Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures, Ann. Neurol., 33, 70, 10.1002/ana.410330112 Kubek, 1998, Prolonged seizure suppression by a single implantable polymeric TRH microdisk preparation, Brain Res., 809, 189, 10.1016/S0006-8993(98)00860-9 Kubera, 1995, Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity, Pol. J. Pharmacol., 47, 321 Kubera, 2001, Immunoreactivity in kainate model of epilepsy, Pol. J. Pharmacol., 53, 541 Landfield, 1998, Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats, Neurobiol. Aging, 19, 469, 10.1016/S0197-4580(98)00079-7 Lemire, 2000, 1,25-dihydroxyvitamin D3—a hormone with immunomodulatory properties, Z. Rheumatol., 59, 24, 10.1007/s003930070034 Lindvall, 1994, Neurotrophins and brain insults, Trends Neurosci., 17, 490, 10.1016/0166-2236(94)90139-2 Mazur-Kolecka, 1996, Effect of hypothalamic lesion or chemical axotomy on restitution of immunoreactivity in mice after cyclophosphamide administration, Int. J. Immunopharmacol., 18, 289, 10.1016/0192-0561(96)00021-5 Neveu, 1994, 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 nut not BDNF mRNA in astrocytes, NeuroReport, 6, 124, 10.1097/00001756-199412300-00032 Neveu, 1994, 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells, Brain Res., Mol. Brain. Res., 24, 70, 10.1016/0169-328X(94)90119-8 Pascual, 2001, BDNF induced glutamate release in cerebrocortical nerve terminals and in cortical astrocytes, NeuroReport, 12, 2673, 10.1097/00001756-200108280-00017 Prufer, 1999, Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord, J. Chem. Neuroanat., 16, 135, 10.1016/S0891-0618(99)00002-2 Racine, 1972, Modification of seizure activity by electrical stimulation. I. After-discharge threshold, Electroencephalogr. Clin. Neurophysiol., 32, 269, 10.1016/0013-4694(72)90176-9 Rosen, 1994, Differential regional and time course increases in thyrotropin-releasing hormone, neuropeptide Y and enkephalin mRNAs following an amygdala kindled seizure, Brain Res., Mol. Brain Res., 27, 71, 10.1016/0169-328X(94)90186-4 Schmidt-Kaster, 1996, Cellular hybridization for BDNF, trkB and NGF mRNAs and BDNF-immunoreactivity in rat forebrain after pilocarpine-induced status epilepticus, Exp. Brain Res., 107, 331, 10.1007/BF00230416 Shi, 1993, Hippocampal input to the hypothalamus inhibits thyrotropin and thyrotropin-releasing hormone gene expression, Neuroendocrinology, 57, 576, 10.1159/000126409 Siegel, 1984, Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats, Brain Res., 298, 125, 10.1016/0006-8993(84)91153-3 Sloviter, 1999, Status epilepticus-induced neuronal injury and network reorganization, Epilepsia, 40, S34, 10.1111/j.1528-1157.1999.tb00876.x Tetich, 2003, Effects of 1alpha,25-dihydroxyvitamin D3 and some putative steroid neuroprotective agents on the hydrogen peroxide-induced damage in neuroblastoma–glioma hybrid NG108–15 cells, Acta Pol. Pharm., 60, 351 Tetich, 2004, Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line, J. Steroid Biochem. Mol. Biol., 89–90, 365, 10.1016/j.jsbmb.2004.03.018 Truettner, 2002, Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain, Mol. Brain Res., 103, 106, 10.1016/S0169-328X(02)00191-2 Turski, 2000, Pilocarpine-induced seizures in rodents—17 years on, Pol. J. Pharmacol., 52, 63 Turski, 1983, Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study, Behav. Brain Res, 9, 315, 10.1016/0166-4328(83)90136-5 Van Tits, 1990, Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process, Am. J. Physiol., 258, E191 Wang, 2000, Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats, Neuropharmacology, 39, 873, 10.1016/S0028-3908(99)00255-5 Yenay, 1999, The neuroprotective potential of heat shock protein (HSP-70), Mol. Med. Today, 51, 525 Young, 1986, Mesencephalic dopamine neurones regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci. U. S. A., 83, 9827, 10.1073/pnas.83.24.9827